InvestorsHub Logo

scottsmith

03/18/17 10:42 AM

#96227 RE: XenaLives #96224

That's the only reason you can think of?

amstocks82

03/18/17 1:48 PM

#96247 RE: XenaLives #96224

At the March 30th presentation, during forum discussions, Missling could talk about the 15 month data if they also release it with a PR.

Then on March 31st, that would be the best time for them to talk about it:

NEW YORK — March 15, 2017 — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, is scheduled to deliver a corporate presentation on Wednesday, March 22, 2017 from 2:10 p.m. to 2:40 p.m. Eastern Daylight Time in the Ambassador Room at the Oppenheimer 27th Annual Healthcare Conference. The conference is being held March 21-22, 2017 at the Westin New York Grand Central Hotel in New York City, NY.

A live webcast and subsequent archived replay of the Company’s presentation may be accessed at https://www.veracast.com/webcasts/opco/healthcare2017/23208578294.cfm or via the investor material page of the Company’s website at www.anavex.com.